Mohammad Sahebkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mohammad Sahebkar has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Abdolghader Assarroudi
Iranian Research Center on Healthy Aging, Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Sabzevar University of Medical Sciences
6 shared publications Ehsan Shahrestanaki
MSc in Epidemiology, Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
5 shared publicationsMaryam Karrabi
Department of Dermatology, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran
4 shared publications- Mohammad Ali Mansournia
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications Akram Taherian
MSc in Nursing, Department of Nursing, School of Nursing, Islamic Azad University, Kashmar Branch, Kashmar, Iran
2 shared publications- Amir Tiyuri
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- 15 May 2026
- Published by Wiley in Journal of Clinical Nursing
- Vol. 35 (9) , 3818-3827
Nursing‐Sensitive Process Indicators Predicting 30‐Day Readmission in Chronic Heart Failure
Aim(s): To identify nursing‐sensitive process indicators documented during hospitalization and at discharge that predict 30‐day hospital readmission among adults with chronic heart failure (CHF). Design: A retrospective case–control study. Methods: This study included 640 adults hospitalized with CHF at two cardiac referral centres in Sabzevar, Iran, between February 2020 and April 2024. Cases were patients readmitted within 30 days of discharge ( n = 320), and controls were patients without readmission during this period ( n = 320). Data were extracted from medical records on nursing‐sensitive process indicators, including in‐hospital falls, fall‐risk identification at admission, structured nursing education at discharge, nursing‐led post‐discharge follow‐up, patient knowledge of prescribed medications, polypharmacy (≥ 4 medications at discharge), and medication dosing frequency. Sociodemographic and clinical characteristics were also collected. Results: In‐hospital falls, identification of fall risk at admission, poor knowledge of prescribed medications, polypharmacy, and complex medication dosing schedules were associated with higher odds of 30‐day readmission. In contrast, receipt of structured nursing education at discharge was associated with a significantly lower likelihood of 30‐day readmission. Conclusion: Nursing‐sensitive process indicators are significant and independent predictors of 30‐day hospital readmission among adults with CHF. Strengthening fall prevention strategies, improving medication‐related education, and enhancing discharge preparation represent actionable nursing interventions to reduce avoidable 30‐day readmission. Implications for the Profession and/or Patient Care: Targeted nursing interventions focused on fall prevention, medication management, and structured discharge education may improve discharge readiness, enhance continuity of care, and reduce preventable 30‐day readmission in patients with CHF. Problem Addressed: Unplanned 30‐day readmission following hospitalization for chronic heart failure remains a persistent challenge for healthcare quality and patient safety. Main Findings: Several nursing‐sensitive process indicators, particularly fall‐related indicators and discharge education, independently predicted readmission risk. Research Impact: The findings support the integration of targeted nursing‐led interventions in cardiac and medical units to reduce readmission risk. Reporting Method: This study was reported in accordance with the STROBE guidelines for observational studies. Patient or Public Contribution: No patient or public involvement was included in the design, conduct, or reporting of this study.
- 15 May 2026
- Published by Wiley in Journal of Clinical Nursing
- Vol. 35 (9) , 3818-3827
Nursing‐Sensitive Process Indicators Predicting 30‐Day Readmission in Chronic Heart Failure
Aim(s): To identify nursing‐sensitive process indicators documented during hospitalization and at discharge that predict 30‐day hospital readmission among adults with chronic heart failure (CHF). Design: A retrospective case–control study. Methods: This study included 640 adults hospitalized with CHF at two cardiac referral centres in Sabzevar, Iran, between February 2020 and April 2024. Cases were patients readmitted within 30 days of discharge ( n = 320), and controls were patients without readmission during this period ( n = 320). Data were extracted from medical records on nursing‐sensitive process indicators, including in‐hospital falls, fall‐risk identification at admission, structured nursing education at discharge, nursing‐led post‐discharge follow‐up, patient knowledge of prescribed medications, polypharmacy (≥ 4 medications at discharge), and medication dosing frequency. Sociodemographic and clinical characteristics were also collected. Results: In‐hospital falls, identification of fall risk at admission, poor knowledge of prescribed medications, polypharmacy, and complex medication dosing schedules were associated with higher odds of 30‐day readmission. In contrast, receipt of structured nursing education at discharge was associated with a significantly lower likelihood of 30‐day readmission. Conclusion: Nursing‐sensitive process indicators are significant and independent predictors of 30‐day hospital readmission among adults with CHF. Strengthening fall prevention strategies, improving medication‐related education, and enhancing discharge preparation represent actionable nursing interventions to reduce avoidable 30‐day readmission. Implications for the Profession and/or Patient Care: Targeted nursing interventions focused on fall prevention, medication management, and structured discharge education may improve discharge readiness, enhance continuity of care, and reduce preventable 30‐day readmission in patients with CHF. Problem Addressed: Unplanned 30‐day readmission following hospitalization for chronic heart failure remains a persistent challenge for healthcare quality and patient safety. Main Findings: Several nursing‐sensitive process indicators, particularly fall‐related indicators and discharge education, independently predicted readmission risk. Research Impact: The findings support the integration of targeted nursing‐led interventions in cardiac and medical units to reduce readmission risk. Reporting Method: This study was reported in accordance with the STROBE guidelines for observational studies. Patient or Public Contribution: No patient or public involvement was included in the design, conduct, or reporting of this study.
- 10 December 2025
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 21 (8) , 3065-3074
Metformin as a potential adjunct in the treatment of mild-to-moderate ulcerative colitis: a double-blind, randomized, placebo-controlled pilot study
Managing relapsing ulcerative colitis (UC) remains a clinical challenge despite therapeutic advances. Metformin, primarily an antidiabetic agent with demonstrated anti-inflammatory properties, has been proposed as an adjunctive treatment for UC. This double-blind, randomized, placebo-controlled pilot trial evaluated the effectiveness of adjunctive metformin in reducing disease activity among patients with mild-to-moderate UC experiencing acute exacerbations. A total of 112 patients with UC were enrolled at Sabzevar, Iran, between 2017 and 2024. The mean age of participants was 34.52 ± 5.79 years, and 57 patients (50.1%) were male. Patients were randomly assigned to receive either 1000 mg metformin tablets twice daily (after breakfast and dinner) in addition to routine treatment or placebo tablets with routine treatment for 2 months. The primary outcome was the change in UC Disease Activity Index (UCDAI) scores after the follow-up period. Ordinal logistic regression demonstrated that the odds of having a higher UCDAI score were approximately 54% lower in the metformin group compared with the control group (OR 0.46; 95% CI 0.21-0.97; P = 0.044). Multiple linear regression further confirmed significantly lower mean UCDAI scores in the metformin group (β = - 1.11; 95% CI - 1.86 to - 0.37; P = 0.004). These findings suggest that adjunctive metformin is associated with meaningful reductions in disease activity scores, supporting its potential therapeutic role in managing acute exacerbations of UC. While the results are promising, larger-scale clinical trials are needed to validate these outcomes and investigate the underlying mechanisms by which metformin may exert its anti-inflammatory effects in UC management.
- 10 December 2025
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 21 (8) , 3065-3074
Metformin as a potential adjunct in the treatment of mild-to-moderate ulcerative colitis: a double-blind, randomized, placebo-controlled pilot study
Managing relapsing ulcerative colitis (UC) remains a clinical challenge despite therapeutic advances. Metformin, primarily an antidiabetic agent with demonstrated anti-inflammatory properties, has been proposed as an adjunctive treatment for UC. This double-blind, randomized, placebo-controlled pilot trial evaluated the effectiveness of adjunctive metformin in reducing disease activity among patients with mild-to-moderate UC experiencing acute exacerbations. A total of 112 patients with UC were enrolled at Sabzevar, Iran, between 2017 and 2024. The mean age of participants was 34.52 ± 5.79 years, and 57 patients (50.1%) were male. Patients were randomly assigned to receive either 1000 mg metformin tablets twice daily (after breakfast and dinner) in addition to routine treatment or placebo tablets with routine treatment for 2 months. The primary outcome was the change in UC Disease Activity Index (UCDAI) scores after the follow-up period. Ordinal logistic regression demonstrated that the odds of having a higher UCDAI score were approximately 54% lower in the metformin group compared with the control group (OR 0.46; 95% CI 0.21-0.97; P = 0.044). Multiple linear regression further confirmed significantly lower mean UCDAI scores in the metformin group (β = - 1.11; 95% CI - 1.86 to - 0.37; P = 0.004). These findings suggest that adjunctive metformin is associated with meaningful reductions in disease activity scores, supporting its potential therapeutic role in managing acute exacerbations of UC. While the results are promising, larger-scale clinical trials are needed to validate these outcomes and investigate the underlying mechanisms by which metformin may exert its anti-inflammatory effects in UC management.
- 18 March 2025
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 80 (5) , 440-446
Enhancing predictive accuracy of the 13-item Acute Coronary Syndrome checklist: a novel approach to improving risk assessment and diagnosis
This study aimed to evaluate the discriminatory capacity of the 13-Item ACS checklist and improve the accuracy of ACS diagnosis through the application of weighted regression analysis. This predictive correlation study enrolled 300 patients admitted to Emergency Department between February 2021 and January 2022. The ACS checklist was administered upon initial triage, followed by patient tracking over a one-month hospitalisation period, capturing ACS diagnoses. Data analysis employed STATA 17 and MEDCALC 20.0.13 software. Findings indicated that patients with sweating and shortness of breath symptoms had a heightened likelihood of true ACS diagnosis by 14% and 11%, respectively, compared to those without ACS (p = 0.005 and 0.019). Conversely, palpitations were associated with a 20% decreased likelihood of authentic ACS diagnosis (p < 0.001). Integration of significant regression coefficients - palpitation severity (-21), sweating severity (13.7), and shortness of breath severity (11) demonstrated significant discriminatory enhancements in the checklists. The weighted 13-item ACS checklist surpassed the unweighted version's performance, yielding superior discriminatory power for ACS diagnosis (p < 0.001 and p = 0.089). The weighted checklist elevated the AUC score from 55% to 70%. Incorporating weighted factors - shortness of breath severity, sweating severity, and palpitations severity - into the checklist notably enhanced ACS identification. However, it's important to note that this tool, while showing promise, is not intended to serve as a standalone diagnostic tool for ACS. Instead, this tool has the potential to enhance risk assessment and aid in clinical decision-making.
- 18 March 2025
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 80 (5) , 440-446
Enhancing predictive accuracy of the 13-item Acute Coronary Syndrome checklist: a novel approach to improving risk assessment and diagnosis
This study aimed to evaluate the discriminatory capacity of the 13-Item ACS checklist and improve the accuracy of ACS diagnosis through the application of weighted regression analysis. This predictive correlation study enrolled 300 patients admitted to Emergency Department between February 2021 and January 2022. The ACS checklist was administered upon initial triage, followed by patient tracking over a one-month hospitalisation period, capturing ACS diagnoses. Data analysis employed STATA 17 and MEDCALC 20.0.13 software. Findings indicated that patients with sweating and shortness of breath symptoms had a heightened likelihood of true ACS diagnosis by 14% and 11%, respectively, compared to those without ACS (p = 0.005 and 0.019). Conversely, palpitations were associated with a 20% decreased likelihood of authentic ACS diagnosis (p < 0.001). Integration of significant regression coefficients - palpitation severity (-21), sweating severity (13.7), and shortness of breath severity (11) demonstrated significant discriminatory enhancements in the checklists. The weighted 13-item ACS checklist surpassed the unweighted version's performance, yielding superior discriminatory power for ACS diagnosis (p < 0.001 and p = 0.089). The weighted checklist elevated the AUC score from 55% to 70%. Incorporating weighted factors - shortness of breath severity, sweating severity, and palpitations severity - into the checklist notably enhanced ACS identification. However, it's important to note that this tool, while showing promise, is not intended to serve as a standalone diagnostic tool for ACS. Instead, this tool has the potential to enhance risk assessment and aid in clinical decision-making.
- 9 July 2024
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 50 (6) , 786-800
Comparison of Performance Characteristics in Early Warning Scoring Tools for Diagnosis of Intubation and Mortality Among COVID-19 Patients
- 9 July 2024
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 50 (6) , 786-800
Comparison of Performance Characteristics in Early Warning Scoring Tools for Diagnosis of Intubation and Mortality Among COVID-19 Patients
- 28 September 2023
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 22 (2) , 1769-1778
Evaluating the effect of acupuncture on symptoms of diabetic peripheral neuropathy (DPN) among individuals with diabetic neuropathy: A single-blind, randomized trial study
Purpose This study aimed to investigate the impact of acupuncture on Diabetic peripheral neuropathy (DPN) symptoms among individuals with diabetic neuropathy. Methods In a single-blind, randomized trial conducted between 2019 and 2020, 60 patients diagnosed with diabetic neuropathy were enrolled. These participants were randomly assigned to either the intervention or control group. The intervention group received real acupuncture alongside routine treatment once a week for seven sessions, each lasting 20 min. Meanwhile, the control group received sham acupuncture as an adjunct to their routine treatment, following the same schedule. To evaluate treatment efficacy, the study assessed primary outcomes, such as pain intensity measured using the Visual Analogue Scale (VAS). Secondary outcomes included evaluating fatigue severity and diabetic peripheral neuropathy (DPN) side effects, measured using the multidimensional fatigue inventory (MFI-20) and a standard questionnaire after each session. Results No statistically significant differences in pain and fatigue scores were observed between the two groups throughout all visits, even after adjusting for baseline characteristics, age, sex, type of diabetes, discopathy, and carpal tunnel syndrome parameters (P > 0.05). The findings did not provide strong evidence supporting a significant effect of real acupuncture compared to sham acupuncture on pain and fatigue values (P = 0.267 and 0.634, respectively). However, the 95% confidence interval for pain scores (-0.35, 1.28) was inconclusive, encompassing effect sizes favoring sham acupuncture. Conclusion Findings suggest that using acupuncture as an adjunctive therapy alongside routine treatment may not lead to a significant reduction in the symptoms of peripheral neuropathy and fatigue severity among individuals with diabetic neuropathy.
- 28 September 2023
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 22 (2) , 1769-1778
Evaluating the effect of acupuncture on symptoms of diabetic peripheral neuropathy (DPN) among individuals with diabetic neuropathy: A single-blind, randomized trial study
Purpose This study aimed to investigate the impact of acupuncture on Diabetic peripheral neuropathy (DPN) symptoms among individuals with diabetic neuropathy. Methods In a single-blind, randomized trial conducted between 2019 and 2020, 60 patients diagnosed with diabetic neuropathy were enrolled. These participants were randomly assigned to either the intervention or control group. The intervention group received real acupuncture alongside routine treatment once a week for seven sessions, each lasting 20 min. Meanwhile, the control group received sham acupuncture as an adjunct to their routine treatment, following the same schedule. To evaluate treatment efficacy, the study assessed primary outcomes, such as pain intensity measured using the Visual Analogue Scale (VAS). Secondary outcomes included evaluating fatigue severity and diabetic peripheral neuropathy (DPN) side effects, measured using the multidimensional fatigue inventory (MFI-20) and a standard questionnaire after each session. Results No statistically significant differences in pain and fatigue scores were observed between the two groups throughout all visits, even after adjusting for baseline characteristics, age, sex, type of diabetes, discopathy, and carpal tunnel syndrome parameters (P > 0.05). The findings did not provide strong evidence supporting a significant effect of real acupuncture compared to sham acupuncture on pain and fatigue values (P = 0.267 and 0.634, respectively). However, the 95% confidence interval for pain scores (-0.35, 1.28) was inconclusive, encompassing effect sizes favoring sham acupuncture. Conclusion Findings suggest that using acupuncture as an adjunctive therapy alongside routine treatment may not lead to a significant reduction in the symptoms of peripheral neuropathy and fatigue severity among individuals with diabetic neuropathy.
- Open Access
- 29 June 2022
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 9 (2) , 63-69
The Prevalence of Nosocomial Infections and Related Microbial Agents Based on the NNIS System in Sabzevar During 2011-2015
Background: Nosocomial infection is an infection that hospitalized patients get while receiving health care. This study aimed to determine the prevalence and factors involved in the incidence of nosocomial infections, related microbial agents, and antibiotic resistance profiles. Methods: This cross-sectional study was conducted on 390 patients with nosocomial infection admitted to Shahid Beheshti Hospital in Sabzevar from 2011 to 2015. The acquired data were assessed by the standard checklist of the National Nosocomial Infections Surveillance (NNIS) system of the Ministry of Health. The collected data were analyzed using the Stata 12 software. Results: Of the 41979 admitted patients during the mentioned period, 390 patients with an average age of 48.08 years suffered from a hospital-acquired infection. The prevalence of nosocomial infections was 1% with the highest rate related to the respiratory tract in men and surgical sites in women. Intravenous catheters, surgical wounds, urinary catheters, suction, ventilator, tracheotomy, and tracheostomy were the most commonly encountered factors (invasive measures) of nosocomial infection, respectively. The most prevalent causes of nosocomial infections were Klebsiella, Staphylococcus aureus, and Acinetobacter. Conclusions: Based on our findings, several factors play a pivotal role in preventing hospital-associated infections, including proper follow-up and timely reporting of nosocomial infection cases. The other influential factors were accurate identification of microorganisms involved, allocation of sufficient funds to provide appropriate facilities for infection prevention, the appropriate and timely medical interventions, and the rational use of antibiotics.
- 29 June 2022
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 9 (2) , 63-69
Open AccessThe Prevalence of Nosocomial Infections and Related Microbial Agents Based on the NNIS System in Sabzevar During 2011-2015
Background: Nosocomial infection is an infection that hospitalized patients get while receiving health care. This study aimed to determine the prevalence and factors involved in the incidence of nosocomial infections, related microbial agents, and antibiotic resistance profiles. Methods: This cross-sectional study was conducted on 390 patients with nosocomial infection admitted to Shahid Beheshti Hospital in Sabzevar from 2011 to 2015. The acquired data were assessed by the standard checklist of the National Nosocomial Infections Surveillance (NNIS) system of the Ministry of Health. The collected data were analyzed using the Stata 12 software. Results: Of the 41979 admitted patients during the mentioned period, 390 patients with an average age of 48.08 years suffered from a hospital-acquired infection. The prevalence of nosocomial infections was 1% with the highest rate related to the respiratory tract in men and surgical sites in women. Intravenous catheters, surgical wounds, urinary catheters, suction, ventilator, tracheotomy, and tracheostomy were the most commonly encountered factors (invasive measures) of nosocomial infection, respectively. The most prevalent causes of nosocomial infections were Klebsiella, Staphylococcus aureus, and Acinetobacter. Conclusions: Based on our findings, several factors play a pivotal role in preventing hospital-associated infections, including proper follow-up and timely reporting of nosocomial infection cases. The other influential factors were accurate identification of microorganisms involved, allocation of sufficient funds to provide appropriate facilities for infection prevention, the appropriate and timely medical interventions, and the rational use of antibiotics.
- 22 June 2022
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 22 (8) , 616-622
Evaluating the effects of telenursing on patients' activities of daily living and instrumental activities of daily living after myocardial infarction: A randomized controlled trial study
Aim: This study aimed to assess the effects of telenursing on patients' activities of daily living and instrumental activities of daily living (ADLs and IADLs) following a myocardial infarction (MI).Methods: This randomized, parallel‐group, controlled trial was conducted on 95 patients post‐MI from 2018 to 2019. Patients were randomly assigned to the intervention (telenursing) and control groups using permuted block randomization. Through telephone calls, telenursing was performed twice a week during the first six consecutive weeks, then once a week until week 12. ADL and IADL questionnaires were completed by both groups before intervention and 12 weeks later. The CONSORT 2010 checklist was used to report the study protocol.Results: The mean age of patients was 56.8 ± 11.07 and 54.2 ± 9.8 years in the telenursing and control group, respectively. The mean ADL and IADL scores in the telenursing group were substantially greater than in the control group [4.57 (3.18, 5.97); P < 0.001 and 4.40 (3.06, 5.75); P < 0.001, respectively]. The odds of a higher degree of independence (no disabilities vs. mild disabilities and disability as well as no disabilities and mild disabilities vs. disability) regarding ADLs and IADLs were significantly greater in the telenursing group as compared with the control group (P < 0.001 and P < 0.001, respectively).Conclusions: Our findings suggest that the use of telenursing intervention may increase patients' ADLs and IADLs after an MI and may enhance their independence. Geriatr Gerontol Int 2022; 22: 616–622.
- 22 June 2022
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 22 (8) , 616-622
Evaluating the effects of telenursing on patients' activities of daily living and instrumental activities of daily living after myocardial infarction: A randomized controlled trial study
Aim: This study aimed to assess the effects of telenursing on patients' activities of daily living and instrumental activities of daily living (ADLs and IADLs) following a myocardial infarction (MI).Methods: This randomized, parallel‐group, controlled trial was conducted on 95 patients post‐MI from 2018 to 2019. Patients were randomly assigned to the intervention (telenursing) and control groups using permuted block randomization. Through telephone calls, telenursing was performed twice a week during the first six consecutive weeks, then once a week until week 12. ADL and IADL questionnaires were completed by both groups before intervention and 12 weeks later. The CONSORT 2010 checklist was used to report the study protocol.Results: The mean age of patients was 56.8 ± 11.07 and 54.2 ± 9.8 years in the telenursing and control group, respectively. The mean ADL and IADL scores in the telenursing group were substantially greater than in the control group [4.57 (3.18, 5.97); P < 0.001 and 4.40 (3.06, 5.75); P < 0.001, respectively]. The odds of a higher degree of independence (no disabilities vs. mild disabilities and disability as well as no disabilities and mild disabilities vs. disability) regarding ADLs and IADLs were significantly greater in the telenursing group as compared with the control group (P < 0.001 and P < 0.001, respectively).Conclusions: Our findings suggest that the use of telenursing intervention may increase patients' ADLs and IADLs after an MI and may enhance their independence. Geriatr Gerontol Int 2022; 22: 616–622.
- 8 February 2021
- Published by Wiley in Journal of Clinical Nursing
- Vol. 30 (11-12) , 1556-1563
Evaluation of the effect of selecting gluteal injection site on the pain injection based on anthropometric indices and body shape pattern: A randomised controlled trial study
Background Pain is one of the common complications of intramuscular injection. Selecting the right place for gluteal injection is one of the challenges of nursing which can increase the safety and success of the injection and thereby reduce the pain severity caused by it. Aim This study was aimed at comparing the effect of injection site selection based on anthropometric indices and body shape pattern on pain injection. Methods In this open‐label randomized controlled trial study, 162 eligible subjects referred to the emergency unit of Vasei Hospital of Sabzevar, Iran were randomly assigned to three groups of control, anthropometric indices and body shape pattern. Subjects in the control group received dorsogluteal injection (traditional way). In the anthropometric group, body mass index (BMI), waist circumference (WC) and anterior superior iliac spine to iliac tubercle (ASIS‐IT), and in body shape pattern group, observed body shape indices (OBS), BMI and sex were used to select the gluteal injection site. Pain injection was assessed using the Visual Analog Scale (VAS). The CONSORT checklist was used. Results The mean age of the participant was 39.43±13.16 and 43.21% (n=70) were male. Based on multiple linear regression analysis, the mean pain injection was substantially lower in body shape pattern as compared to the control group (r2: 0.26; bxy= ‐0.41; 95% CI: ‐0.81, ‐0.01; P = 0.043). the mean pain injection was significantly greater in the left leg injection than right one (r2: 0.26; bxy= 0.44; 95% CI: 0.06, 0.81; P = 0.021). Conclusion Findings of this study suggest that the selection of a gluteal injection site based on body shape pattern in comparison with traditional dorsogluteal injection method has a significant effect on pain injection relief. Relevance to clinical practice Nurses can choose the appropriate gluteal injection site based on the body shape pattern to reduce the pain of the intramuscular (IM) gluteal injections.
- 8 February 2021
- Published by Wiley in Journal of Clinical Nursing
- Vol. 30 (11-12) , 1556-1563
Evaluation of the effect of selecting gluteal injection site on the pain injection based on anthropometric indices and body shape pattern: A randomised controlled trial study
Background Pain is one of the common complications of intramuscular injection. Selecting the right place for gluteal injection is one of the challenges of nursing which can increase the safety and success of the injection and thereby reduce the pain severity caused by it. Aim This study was aimed at comparing the effect of injection site selection based on anthropometric indices and body shape pattern on pain injection. Methods In this open‐label randomized controlled trial study, 162 eligible subjects referred to the emergency unit of Vasei Hospital of Sabzevar, Iran were randomly assigned to three groups of control, anthropometric indices and body shape pattern. Subjects in the control group received dorsogluteal injection (traditional way). In the anthropometric group, body mass index (BMI), waist circumference (WC) and anterior superior iliac spine to iliac tubercle (ASIS‐IT), and in body shape pattern group, observed body shape indices (OBS), BMI and sex were used to select the gluteal injection site. Pain injection was assessed using the Visual Analog Scale (VAS). The CONSORT checklist was used. Results The mean age of the participant was 39.43±13.16 and 43.21% (n=70) were male. Based on multiple linear regression analysis, the mean pain injection was substantially lower in body shape pattern as compared to the control group (r2: 0.26; bxy= ‐0.41; 95% CI: ‐0.81, ‐0.01; P = 0.043). the mean pain injection was significantly greater in the left leg injection than right one (r2: 0.26; bxy= 0.44; 95% CI: 0.06, 0.81; P = 0.021). Conclusion Findings of this study suggest that the selection of a gluteal injection site based on body shape pattern in comparison with traditional dorsogluteal injection method has a significant effect on pain injection relief. Relevance to clinical practice Nurses can choose the appropriate gluteal injection site based on the body shape pattern to reduce the pain of the intramuscular (IM) gluteal injections.
- 2 September 2020
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 313 (7) , 539-547
Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study
This study was aimed at evaluating the efficacy of Tranexamic Acid (TA) mesotherapy versus cysteamine 5% cream in the treatment of melasma. This single-blind, randomized clinical trial was conducted among 54 subjects between 2018 and 2019. Cysteamine 5% cream group was instructed to apply the cream on the melasma lesions 30 min before bed for 4 consecutive months. Conversely, 0.05 mL (4 mg/mL) TA mesotherapy was performed by a physician every 4 weeks until 2 months. The severity of melasma was evaluated using both Dermacatch® device and the modified Melasma Area Severity Index (mMASI). The most remarkable improvement rate was observed in the TA group at the third visit based on mMASI and Dermacatch® values at 47% and 15% in turn. The mMASI scores were substantially improved in both groups at the second visit (cysteamine vs TA 8.48 ± 2.34 and 7.03 ± 3.19; P = 0.359) and third visit (cysteamine vs TA 6.32 ± 2.11 and 5.52 ± 2.55; P = 0.952) as compared to baseline (cysteamine vs TA: 11.68 ± 2.70 and 10.43 ± 2.69). Dermacatch® values were significantly declined at the second and third visits (cysteamine vs TA 42.54 ± 12.84 and 38.75 ± 9.80, P = 0.365; 40.74 ± 12.61 and 36.17 ± 10.3, P = 0.123, respectively) compared with baseline (cysteamine vs TA 45.76 ± 13.41 and 42.41 ± 10.48), although the improvement rates between two groups were not significantly different. Findings suggest that none of the cysteamine and TA mesotherapy treatments measured by both mMASI and Dermacatch® methods have substantial advantages over the other; however, complications are less in the cysteamine than the TA mesotherapy group.
- 2 September 2020
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 313 (7) , 539-547
Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study
This study was aimed at evaluating the efficacy of Tranexamic Acid (TA) mesotherapy versus cysteamine 5% cream in the treatment of melasma. This single-blind, randomized clinical trial was conducted among 54 subjects between 2018 and 2019. Cysteamine 5% cream group was instructed to apply the cream on the melasma lesions 30 min before bed for 4 consecutive months. Conversely, 0.05 mL (4 mg/mL) TA mesotherapy was performed by a physician every 4 weeks until 2 months. The severity of melasma was evaluated using both Dermacatch® device and the modified Melasma Area Severity Index (mMASI). The most remarkable improvement rate was observed in the TA group at the third visit based on mMASI and Dermacatch® values at 47% and 15% in turn. The mMASI scores were substantially improved in both groups at the second visit (cysteamine vs TA 8.48 ± 2.34 and 7.03 ± 3.19; P = 0.359) and third visit (cysteamine vs TA 6.32 ± 2.11 and 5.52 ± 2.55; P = 0.952) as compared to baseline (cysteamine vs TA: 11.68 ± 2.70 and 10.43 ± 2.69). Dermacatch® values were significantly declined at the second and third visits (cysteamine vs TA 42.54 ± 12.84 and 38.75 ± 9.80, P = 0.365; 40.74 ± 12.61 and 36.17 ± 10.3, P = 0.123, respectively) compared with baseline (cysteamine vs TA 45.76 ± 13.41 and 42.41 ± 10.48), although the improvement rates between two groups were not significantly different. Findings suggest that none of the cysteamine and TA mesotherapy treatments measured by both mMASI and Dermacatch® methods have substantial advantages over the other; however, complications are less in the cysteamine than the TA mesotherapy group.